COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Purpose

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Conditions

  • Diabetic Macular Edema
  • DME
  • Diabetic Macular Edema (DME)

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Previously treated or treatment naïve patients with a documented diagnosis of macular edema associated with diabetic retinopathy (DR) in the study eye, with onset of disease that began at any time prior to the Screening Visit. - Best-corrected visual acuity (BCVA) Early Treatment Diabetic Retinopathy Study (ETDRS) letter score of 35 letters (20/200 Snellen equivalent) to 78 letters (20/32 Snellen equivalent) in the study eye at the Screening Visit and at Baseline (Day 1). - For previously treated participants: at least 1 injection of anti-VEGF in the past 12 months, the most recent anti-VEGF treatment for DME must not have been administered less than 12 weeks prior to the Screening Visit.

Exclusion Criteria

  • BCVA using ETDRS charts <30 letters (20/250 Snellen equivalent) in the fellow eye.

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
EYP-1901 2686 µg
EYP-1901
  • Drug: EYP-1901
    Intravitreal Injection
Active Comparator
Aflibercept
  • Drug: Aflibercept (2.0 mg)
    Intravitreal Injection

Recruiting Locations

California Retina Consultants
Bakersfield, California 93309
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

The Retina Partners
Encino, California 91436
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Global Research Management, Inc.
Glendale, California 91204
Contact:
Clinical Project Manager
833-393-7646
info@eyepointpharma.com

Northern California Retina Vitreous Associates Medical Group INC.
Mountain View, California 94040
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Consultants of San Diego
Poway, California 92064
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

California Eye Specialists Medical Group, Inc.
Redlands, California 92373
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retinal Consultants Medical Group - Parkcenter Drive
Sacramento, California 95825
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retinal Consultants Medical Group
Sacramento, California 95841
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Colorado Retina Associates
Lakewood, Colorado 80228
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Advance Medical Research Group, Inc
Deerfield Beach, Florida 33064
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Eye Associates of Pinellas
Pinellas Park, Florida 33782
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Southern Vitreoretinal Associates
Tallahassee, Florida 32308
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Specialists of Tampa
Wesley Chapel, Florida 33544
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Georgia Retina
Marietta, Georgia 30060
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Consultants of Hawaii
‘Aiea, Hawaii 96701
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Red River Research Partners
Plainfield, Illinois 60586
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Midwest Eye Institute - Carmel
Carmel, Indiana 11220
Contact:
Clinical Project Manager
833-393-7646
info@eyepointpharma.com

Haik Humble Eye Center
West Monroe, Louisiana 71291
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

New England Retina Consultants
Springfield, Massachusetts 01107
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Associates of Michigan
Grand Blanc, Michigan 48439
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Foundation for Vision Research
Grand Rapids, Michigan 49546
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

NJ Retina - Toms River
Toms River, New Jersey 08755
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Associates of Western New York
Rochester, New York 14620
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

VRCNY/Long Island Vitreoretinal Consultants
Westbury, New York 11590
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Asheville Eye Associates - Regional Medical Park
Asheville, North Carolina 28803
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Cape Fear Retinal Associates, PC
Wilmington, North Carolina 28401
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Piedmont Retina Specialists, P.A. - Winston-Salem Office
Winston-Salem, North Carolina 27103
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Tulsa Retina Consultant
Tulsa, Oklahoma 74114
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Erie Retina Research
Erie, Pennsylvania 16507
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Charleston Neuroscience Institute - Beaufort
Beaufort, South Carolina 29902
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Tennessee Retina
Nashville, Tennessee 37203
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Research Institute of Texas Integrated Clinical Research
Abilene, Texas 79606
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Texas Retina Associates
Dallas, Texas 75231
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Mt. Olympus Medical Research
Houston, Texas 77479
Contact:
Clinical Project Manager
833-393-7646
info@eyepointpharma.com

Retina Consultants of Texas
Katy, Texas 77494
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Texas Retina Associates
Plano, Texas 75075
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Consultants of Texas
Schertz, Texas 78154
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Salt Lake Retina
West Jordan, Utah 84088
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Piedmont Eye Center
Lynchburg, Virginia 24502
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

More Details

Status
Recruiting
Sponsor
EyePoint Pharmaceuticals, Inc.

Study Contact

Ramiro Ribeiro, MD, PhD
833-393-7646
rribeiro@eyepoint.bio